Corient Private Wealth’s Abbott ABT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$171M Sell
1,667,187
-3,241,369
-66% -$366M 0.24% 82
2025
Q4
$528M Buy
4,908,556
+2,835,869
+137% +$361M 0.35% 52
2025
Q3
$277M Sell
2,072,687
-80,007
-4% -$10.5M 0.44% 42
2025
Q2
$293M Buy
2,152,694
+203,617
+10% +$26.9M 0.39% 48
2025
Q1
$259M Sell
1,949,077
-326,190
-14% -$41.5M 0.42% 46
2024
Q4
$257M Sell
2,275,267
-99,175
-4% -$11.5M 0.43% 49
2024
Q3
$271M Buy
2,374,442
+41,649
+2% +$4.57M 0.42% 47
2024
Q2
$242M Sell
2,332,793
-58,516
-2% -$6.2M 0.42% 44
2024
Q1
$272M Sell
2,391,309
-58,219
-2% -$6.67M 0.48% 39
2023
Q4
$270M Buy
2,449,528
+234,519
+11% +$23.4M 0.5% 37
2023
Q3
$215M Sell
2,215,009
-25,599
-1% -$2.69M 0.49% 41
2023
Q2
$244M Buy
2,240,608
+92,787
+4% +$9.89M 0.56% 34
2023
Q1
$217M Buy
2,147,821
+661,171
+44% +$69.8M 0.58% 36
2022
Q4
$163M Buy
+1,486,650
New +$154M 0.59% 36

Other funds holding ABT

Corient Private Wealth's ABT Position: Q1 2026 in Review

Corient Private Wealth reduced its Abbott (ABT) stake by 66% in Q1 2026, selling an estimated $366M and leaving 1,667,187 shares worth $171M. The position accounts for 0.24% of the portfolio, ranked #82.

Corient Private Wealth first reported a position in ABT in Q4 2022 and has held it in 14 quarters since. The position peaked at $528M in Q4 2025. 3,086 funds tracked by Wall St. Rank hold ABT as of Q1 2026.

  • Corient Private Wealth held 1,667,187 shares of Abbott worth $171M as of Q1 2026.
  • Corient Private Wealth sold 3,241,369 Abbott shares in Q1 2026, an estimated $366M.
  • Abbott made up 0.24% of Corient Private Wealth's portfolio in Q1 2026, its #82 holding.
  • Corient Private Wealth first reported a position in Abbott in Q4 2022 and has held it in 14 quarters since.
  • Corient Private Wealth's Abbott position peaked at $528M in Q4 2025.
  • 3,086 funds tracked by Wall St. Rank held Abbott as of Q1 2026.

Based on Corient Private Wealth's 13F filing for Q1 2026, filed 15 May 2026.